Skip to content

Gaze and Gait Training With rTMS

Gaze and Gait Training With Neuromodulation

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05864313
Enrollment
30
Registered
2023-05-18
Start date
2027-01-01
Completion date
2028-09-01
Last updated
2026-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Cognitive Impairment

Brief summary

The purpose of this study is to evaluate the feasibility of combining repetitive transcranial magnetic stimulation (rTMS), gaze and gait training to improve walking and balance in people with or without mild cognitive impairment.

Detailed description

The study plan is to recruit a total of 15 cognitively impaired and 15 healthy adults. The study will involve two visits. Each study visit will involve: * Real rTMS or sham rTMS that last about 60 minutes * Gaze stabilization exercise via a virtual reality headset for about 1-hour * Target stepping on a treadmill for about 1-hour Researchers will compare changes in gaze and gait following training sessions with real rTMS and sham rTMS.

Interventions

DEVICERepetitive Transcranial Magnetic Stimulation (rTMS)

10 Hz rTMS for 5 seconds over the frontal eye fields with 25 second intertrain interval for 10 trains (500 pulses) at 90% of the resting motor threshold,

BEHAVIORALGait training

Subjects will practice stepping on virtual targets with real-time feedback of their foot position displayed on a screen while walking on a treadmill.

BEHAVIORALGaze training

Subjects will perform gaze stabilization and gaze shifting exercise via a virtual reality headset.

DEVICESham rTMS

Sham rTMS stimulation will produce discharge noise and vibration without stimulating the cerebral cortex.

Sponsors

University of Florida
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age 18 - 80 years * Capable of providing informed consent and complying to the experimental procedures

Exclusion criteria

* Significant gait difficulty requiring ambulatory aids * Presence of implanted device such as a neurostimulator, cochlear implant or pacemaker * History of epilepsy * History of hearing issues

Design outcomes

Primary

MeasureTime frameDescription
Change in Foot Placement Error from baseline 1Beginning and end of Visit 1, an average of 8 hoursFoot position relative to stepping targets.
Change in VOR Gain from baseline 1Beginning and end of Visit 1, an average of 8 hoursThe amount of eye relative to head movement during active head rotations.
Change in Foot Placement Error from baseline 2Beginning and end of Visit 2, an average of 8 hoursFoot position relative to stepping targets.
Change in VOR Gain from baseline 2Beginning and end of Visit 2, an average of 8 hoursThe amount of eye relative to head movement during active head rotations.

Secondary

MeasureTime frameDescription
Change in Timed Up and Go (TUG) from baseline 1Beginning and end of Visit 1, an average of 8 hoursThe TUG assesses mobility, balance, waking ability and fall risk in older adults. A higher risk for falling is indicated by \>= 12 seconds to complete the test.
Change in Timed Up and Go (TUG) from baseline 2Beginning and end of Visit 2, an average of 8 hoursThe TUG assesses mobility, balance, waking ability and fall risk in older adults. A higher risk for falling is indicated by \>= 12 seconds to complete the test.

Contacts

PRINCIPAL_INVESTIGATORJulia Choi, Ph.D.

University of Florida

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 7, 2026